Mihue Jang

9PUBLICATIONS
16CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Microbial ecologyReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 10, 2026
Rapid CAR screening and circRNA-driven CAR-NK cells for persistent shed-resistant immunotherapy.

Joo-Yoon Chung, Jisu Hong, Su-Min Yee

|Jul 25, 2025
Identification of 5,7-Dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one Derivatives as ENPP1 Inhibitors for STING Pathway-Mediated Immunotherapy.

Su Hyun Ji, Miso Kang, Hyomin Ahn

|May 09, 2025
Cytokines in Focus: IL-2 and IL-15 in NK Adoptive Cell Cancer Immunotherapy.

Bryan Marr, Donghyeon Jo, Mihue Jang

|Feb 27, 2023
Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6.

Young Eun Lee, Ga-Yeon Go, Eun-Young Koh

|Dec 23, 2021
Facile discovery of a therapeutic agent for NK-mediated synergistic antitumor effects using a patient-derived 3D platform.

Young Eun Lee, Chae Min Yuk, Minseok Lee

|Oct 04, 2019
MiR-195 and miR-497 suppress tumorigenesis in lung cancer by inhibiting SMURF2-induced TGF-β receptor I ubiquitination.

Dong-Kyu Chae, Jinyoung Park, Moonsoo Cho

Pageof 2

Frequent Collaborators

2 joint publications

Seung-Hwan Lee

1 joint publications

Ki Chang Nam

1 joint publications

Kwideok Park

1 joint publications

Seung Ja Oh